Wewers M D, Rennard S I, Hance A J, Bitterman P B, Crystal R G
J Clin Invest. 1984 Dec;74(6):2208-18. doi: 10.1172/JCI111647.
Interleukin-1 (IL-1) is a mediator released by stimulated mononuclear phagocytes that is thought to play an important role in modulating T and B lymphocyte activation as well as in contributing to the febrile response and other inflammatory processes. Circulating mononuclear phagocytes, blood monocytes, readily release IL-1 when stimulated. However, the ability of lung mononuclear phagocytes, alveolar macrophages, to dispose of the large daily burden of inhaled antigens without stimulating an inflammatory response suggests that the release of IL-1 by alveolar macrophages may differ significantly from that of blood monocytes. To evaluate this hypothesis, normal autologous alveolar macrophages, obtained by bronchoalveolar lavage, were compared with blood monocytes for their ability to release IL-1 in response to a standard stimulus, lipopolysaccharide (LPS). Alveolar macrophages were found to be at least 1,000 times less sensitive to LPS than blood monocytes. Furthermore, alveolar macrophages released significantly less IL-1 than blood monocytes (26 +/- 11 vs. 128 +/- 21 U/10(6) cells X 24 h, respectively, after stimulation with 10 micrograms/ml of LPS, P less than 0.001). This difference was not due to the release of substances by macrophages, which inhibited lymphocyte proliferation in response to IL-1, or to degradation of IL-1 by macrophages. Culturing macrophages in the presence of indomethacin and dialysis of macrophage supernatants did not affect the difference, and culturing macrophages with monocytes did not decrease detectable IL-1 activity from the monocytes. The IL-1 produced by the two cell types was indistinguishable by anion-exchange chromatography, gel filtration, and isoelectric focusing. In addition, consistent with the findings for alveolar macrophages, macrophages generated by the in vitro maturation of blood monocytes were also deficient in their ability to release IL-1. These findings suggest that if the population of alveolar macrophages obtained by bronchoalveolar lavage represents the total in vivo population of alveolar macrophages, although normal human macrophages are capable of IL-1 release, they are relatively limited in this ability, and this limitation seems to be linked to the maturational state of the mononuclear phagocyte. These observations may explain, in part, the ability of alveolar macrophages to clear the airspaces of foreign antigens without extensive activation of other pulmonary inflammatory and immune effector cells.
白细胞介素-1(IL-1)是一种由受刺激的单核吞噬细胞释放的介质,被认为在调节T和B淋巴细胞活化以及引发发热反应和其他炎症过程中发挥重要作用。循环单核吞噬细胞,即血液中的单核细胞,在受到刺激时很容易释放IL-1。然而,肺单核吞噬细胞,即肺泡巨噬细胞,能够处理每日吸入的大量抗原而不引发炎症反应,这表明肺泡巨噬细胞释放IL-1的方式可能与血液单核细胞有显著差异。为了评估这一假设,通过支气管肺泡灌洗获得的正常自体肺泡巨噬细胞与血液单核细胞在对标准刺激脂多糖(LPS)的反应中释放IL-1的能力进行了比较。发现肺泡巨噬细胞对LPS的敏感性至少比血液单核细胞低1000倍。此外,肺泡巨噬细胞释放的IL-1明显少于血液单核细胞(分别在用10微克/毫升LPS刺激后,每10⁶个细胞×24小时释放26±11单位与128±21单位,P<0.001)。这种差异不是由于巨噬细胞释放了抑制淋巴细胞对IL-1反应增殖的物质,也不是由于巨噬细胞对IL-1的降解。在吲哚美辛存在下培养巨噬细胞以及对巨噬细胞上清液进行透析都不影响这种差异,并且将巨噬细胞与单核细胞一起培养也不会降低单核细胞中可检测到的IL-1活性。通过阴离子交换色谱、凝胶过滤和等电聚焦法,两种细胞类型产生的IL-1无法区分。此外,与肺泡巨噬细胞的发现一致,通过血液单核细胞体外成熟产生的巨噬细胞释放IL-1的能力也不足。这些发现表明,如果通过支气管肺泡灌洗获得的肺泡巨噬细胞群体代表体内肺泡巨噬细胞的总数,那么尽管正常人类巨噬细胞能够释放IL-1,但其在这方面的能力相对有限,而且这种限制似乎与单核吞噬细胞的成熟状态有关。这些观察结果可能部分解释了肺泡巨噬细胞在不广泛激活其他肺部炎症和免疫效应细胞的情况下清除气道中异物抗原的能力。